| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.11 | 0.4 |